Company / Revenue
iSpecimen Inc. Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$9.3M
FY2025
5-year range
$8.2M / $11.1M
FY2021-FY2025
Trend
-6.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has declined for 3 consecutive years, from $11M in FY2022 to $9M in FY2025.
Based on SEC 10-K filings.
$9M in FY2025 with a 3-year CAGR of -5.9%.
Declined from $10M to $9M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -5.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- iSpecimen Inc.'s revenue has declined for 3 consecutive years.
- 3-year CAGR of -5.9%, indicating a declining trend.
- In FY2025, revenue decreased 6.4% year-over-year.
- Peak revenue was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.90 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.3M | -6.4% |
| FY2024 | $9.9M | -4.6% |
| FY2023 | $10.4M | -6.6% |
| FY2022 | $11.1M | +36.1% |
| FY2021 | $8.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026